一名新冠病毒检测呈阳性孕妇的持续性胎儿室上性心动过速
Persistent Fetal SVT in a COVID-19 Positive Pregnancy.
作者信息
Wang Gloria, Stapley Eric, Peterson Sara, Parrott Jessica, Clark-Ganheart Cecily
机构信息
Overland Park Regional Medical Center. HCA Graduate Medical Education-ObGyn, 12200 W. 106th St, Suite 325, Overland Park, KS 66215, USA.
Kansas City University of Medicine and Biosciences, 1750 Independence Ave, Kansas City, MO 64106, USA.
出版信息
Case Rep Obstet Gynecol. 2022 Jan 7;2022:9933520. doi: 10.1155/2022/9933520. eCollection 2022.
BACKGROUND
Rapid introduction and spread of SARS-CoV-2 have posed unique challenges in understanding the disease, role in vertical transmission, and in developing management. We present a case of a patient with COVID-19 infection and fetus with new-onset fetal SVT.
CASE
A 26-year-old gravida 4 para 2012 with third trimester COVID-19 infection was diagnosed with new onset fetal SVT. Successful cardioversion was achieved with flecainide. The patient was followed outpatient until induction of labor at 39 and 3/7 weeks of gestational age resulting in an uncomplicated vaginal delivery. Postpartum course was uncomplicated.
CONCLUSION
Fetal SVT is a potential complication of maternal COVID-19 infection. The use of transplacental therapy with flecainide is an appropriate alternative to digoxin in these cases.
背景
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的迅速出现和传播给了解该疾病、其在垂直传播中的作用以及制定管理措施带来了独特挑战。我们报告一例新型冠状病毒肺炎（COVID-19）感染患者及胎儿发生新发胎儿室上性心动过速（SVT）的病例。
病例
一名26岁、孕4产2012、妊娠晚期感染COVID-19的孕妇被诊断为新发胎儿SVT。使用氟卡尼成功进行了心脏复律。患者在门诊随访，直至孕39周加3/7周引产，分娩过程顺利，为经阴道分娩。产后过程无并发症。
结论
胎儿SVT是孕妇COVID-19感染的潜在并发症。在这些病例中，使用氟卡尼经胎盘治疗是替代地高辛的合适选择。
Zotero 插件